Ciresi A - Search Results

1

The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.

Guarnotta V, Amato MC, Pivonello R, Arnaldi G, Ciresi A, Trementino L, Citarrella R, Iacuaniello D, Michetti G, Simeoli C, Colao A, Giordano C. Guarnotta V, et al. Among authors: ciresi a. Endocrine. 2017 Feb;55(2):564-572. doi: 10.1007/s12020-016-0914-9. Epub 2016 Mar 10. Endocrine. 2017. PMID: 26965912

2

Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?

Giordano C, Guarnotta V, Pivonello R, Amato MC, Simeoli C, Ciresi A, Cozzolino A, Colao A. Giordano C, et al. Among authors: ciresi a. Eur J Endocrinol. 2013 Dec 21;170(2):311-9. doi: 10.1530/EJE-13-0754. Print 2014 Feb. Eur J Endocrinol. 2013. PMID: 24255133

3

Adrenal morphology and function in acromegalic patients in relation to disease activity.

Ciresi A, Amato MC, Vetro C, Lo Coco R, Galluzzo A, Giordano C. Ciresi A, et al. Endocrine. 2009 Oct;36(2):346-54. doi: 10.1007/s12020-009-9230-y. Epub 2009 Aug 14. Endocrine. 2009. PMID: 19685191

4

Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.

Ciresi A, Amato MC, Guarnotta V, Lo Castro F, Giordano C. Ciresi A, et al. Clin Endocrinol (Oxf). 2013 Dec;79(6):845-52. doi: 10.1111/cen.12204. Epub 2013 Apr 22. Clin Endocrinol (Oxf). 2013. PMID: 23506485

5

Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index.

Di Somma C, Ciresi A, Amato MC, Savastano S, Savanelli MC, Scarano E, Colao A, Giordano C. Di Somma C, et al. Among authors: ciresi a. Endocrine. 2015 Jun;49(2):492-502. doi: 10.1007/s12020-014-0471-z. Epub 2014 Nov 9. Endocrine. 2015. PMID: 25381601

6

The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Ciresi A, Radellini S, Guarnotta V, Giordano C. Ciresi A, et al. Endocrine. 2017 Jun;56(3):579-588. doi: 10.1007/s12020-016-1076-5. Epub 2016 Aug 13. Endocrine. 2017. PMID: 27520559

7

Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease.

Guarnotta V, Ciresi A, Pitrone M, Pizzolanti G, Giordano C. Guarnotta V, et al. Among authors: ciresi a. Endocrine. 2018 Feb;59(2):454-457. doi: 10.1007/s12020-017-1276-7. Epub 2017 Mar 17. Endocrine. 2018. PMID: 28303515 No abstract available.

8

The metabolic outcomes of growth hormone treatment in children are gender specific.

Ciresi A, Radellini S, Guarnotta V, Mineo MG, Giordano C. Ciresi A, et al. Endocr Connect. 2018 Jul;7(7):879-887. doi: 10.1530/EC-18-0135. Epub 2018 Jun 20. Endocr Connect. 2018. PMID: 29925523 Free PMC article.

9

Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease.

Barbot M, Guarnotta V, Zilio M, Ceccato F, Ciresi A, Daniele A, Pizzolanti G, Campello E, Frigo AC, Giordano C, Scaroni C. Barbot M, et al. Among authors: ciresi a. Endocrine. 2018 Oct;62(1):207-214. doi: 10.1007/s12020-018-1669-2. Epub 2018 Jul 6. Endocrine. 2018. PMID: 29980915

10

No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.

Amato MC, Guarnotta V, Ciresi A, Modica R, Pantò F, Giordano C. Amato MC, et al. Among authors: ciresi a. J Clin Endocrinol Metab. 2014 Jan;99(1):203-11. doi: 10.1210/jc.2013-2669. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24243639 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters